BSECompany Update23 Jun 2026 · 23 Jun 2026, 04:34 pm
Campaign for KYC and other related updations and shareholders engagement to prevent transfer of unclaimed dividend to IEPF
Marksans Pharma Ltd · 524404
✦ AI Summary
Marksans Pharma Ltd has initiated a 'Saksham Niveshak' campaign, a second 100-day drive, following guidance from the Ministry of Corporate Affairs (MCA). The campaign aims to assist shareholders in updating their KYC details, registering nominations, and claiming unclaimed dividends from Financial Year 2018-19 onwards. This proactive measure seeks to prevent these unclaimed dividends from being transferred to the Investor Education and Protection Fund (IEPF). Shareholders are encouraged to contact the Company's Registrar and Transfer Agent (RTA) or Company Secretary for assistance before the deadline of July 08, 2026.
Analysis Scores
Earnings Impact3/10
Growth Catalyst1/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact1/10
Market Sentiment4/10
Full Announcement
Marksans Pharma Ltd - 524404 - DISCLOSURE REGARDING SECOND 100 DAY CAMPAIGN - "SAKSHAM NIVESHAK"